Results 201 to 210 of about 1,682,340 (366)

Targeting PTPN22 at Nonorthosteric Binding SitesA Fragment Approach. [PDF]

open access: yesACS Omega
Di Lello P   +18 more
europepmc   +1 more source

Binding energies of the GCMS identified compounds from dichloromethane fraction docked in the active sites of Candida albicans Sterol 14-alpha demethylase (5TZ1) and Escherichia coli DNA gyrase subunit B (6YD9).

open access: green
Oluwatoyin Temilolu Adebayo (21030152)   +4 more
openalex   +1 more source

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

AF2BIND: predicting small-molecule binding sites using the pair representation of AlphaFold2. [PDF]

open access: yesNat Methods
Gazizov A   +5 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Atomically Precise Engineering of Synergistic Binding Sites in a Zirconium Metal-Organic Framework for the Capture of Perfluorooctanoic Acid. [PDF]

open access: yesJ Am Chem Soc
Marugán-Benito S   +8 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

Unraveling Synthetase's Mode of Action: The Pyrrolysyl-tRNA Synthetase Dimer Uses Secondary Binding Sites in the Cell. [PDF]

open access: yesAngew Chem Int Ed Engl
Dröden J   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy